Collaborative Opportunities for Multiple-disciplinary, Bold, and Innovative Neuroscience (COMBINE) (RM1 Clinical Trial Optional)
ID: 360396Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH) is announcing a forthcoming funding opportunity titled "Collaborative Opportunities for Multiple-disciplinary, Bold, and Innovative Neuroscience (COMBINE)," aimed at fostering innovative research in neuroscience through collaborative team science. This initiative encourages applications from transdisciplinary teams of 3-6 principal investigators (PDs/PIs) to tackle complex research questions that can lead to significant advancements in the field, particularly in overcoming barriers and achieving paradigm shifts in neuroscience. The program is designed to support projects that integrate diverse expertise across basic, clinical, and translational neuroscience domains, with the goal of transforming knowledge and practice within a five-year timeframe. Interested applicants are encouraged to prepare for this opportunity, with an estimated synopsis posting date of February 4, 2026, and a closing date for applications expected on June 23, 2026. For further inquiries, potential applicants can contact the NINDS Team Science Group at NINDSteamscience@nih.gov or by phone at 240-328-3447.

    Point(s) of Contact
    Files
    No associated files provided.
    Similar Opportunities
    BRAIN Initiative: Integrative Team-Research BRAIN Circuits Program - iTeamBCP (RM1 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing the BRAIN Initiative: Integrative Team-Research BRAIN Circuits Program (iTeamBCP), which aims to solicit applications from collaborative teams to explore the relationship between the nervous system's components and mental experiences. This program encourages teams of 3-6 Principal Investigators (PIs) to integrate diverse expertise in neuroscience and related fields to develop innovative approaches that bridge cellular, circuit, and behavioral analyses, ultimately enhancing understanding of central nervous system (CNS) functions. While applications are not currently being accepted, interested investigators are encouraged to prepare for this opportunity, which will utilize the RM1 activity code, with an estimated synopsis posting date of February 4, 2026, and a projected award date of April 1, 2027. For further inquiries, potential applicants can contact Dr. Karen K. David at 240-328-3447 or via email at BRAINCircuits@NIH.GOV.
    Forecast for NIH Blueprint and BRAIN Initiative ACTION Potential Program (F99/K00 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to announce a funding opportunity titled "Forecast for NIH Blueprint and BRAIN Initiative ACTION Potential Program (F99/K00 Clinical Trial Not Allowed)" aimed at supporting neuroscience graduate students. This initiative, under the NIH Blueprint for Neuroscience Research and the BRAIN Initiative, will provide a two-phase F99/K00 award designed to facilitate the completion of doctoral dissertations and assist in the transition to postdoctoral positions in neuroscience research. The program is crucial for developing the next generation of independent neuroscience researchers, emphasizing the importance of collaboration and project responsiveness. Interested applicants are encouraged to prepare in advance, as applications will not be solicited until the official announcement, which is expected to be published on November 3, 2025, with a closing date for submissions anticipated on March 20, 2026. For further inquiries, potential applicants can contact Dr. Lauren Ullrich at the National Institute of Neurological Disorders and Stroke via email at nindsotwd@ninds.nih.gov or by phone at 301-451-7964.
    Discovery of in vivo Chemical Probes for the Nervous System
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) aimed at supporting the discovery of in vivo chemical probes for the nervous system, specifically targeting novel brain mechanisms. This initiative, led by the National Institute on Aging (NIA) in collaboration with the National Eye Institute (NEI), the National Institute on Drug Abuse (NIDA), and the National Institute of Mental Health (NIMH), seeks applicants who possess validated starting compounds for chemical optimization and bioassays to explore new analog compounds. The focus will be on developing small molecules that can enhance understanding of biological processes relevant to brain diseases, with an emphasis on innovative biological targets. Interested applicants can reach out to Dr. Paul G. Grothaus at grothausp@mail.nih.gov or call 240-688-6634 for further information, with the estimated synopsis posting date set for February 26, 2026, and a projected award date of April 5, 2027.
    Joint NINDS/NIMH Exploratory Neuroscience Research Grant (R21 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Joint NINDS/NIMH Exploratory Neuroscience Research Grant (R21 Clinical Trial Not Allowed) to support innovative and exploratory research projects in neuroscience. This grant program is designed for early-stage projects that align with the missions of the National Institute of Neurological Disorders and Stroke (NINDS) and the National Institute of Mental Health (NIMH), focusing on studies that assess the feasibility of novel investigations with the potential for significant breakthroughs in neuroscience. Eligible applicants include a wide range of organizations such as educational institutions, nonprofits, and foreign entities, with funding available up to $275,000 over two years. The application period opens on January 16, 2025, with anticipated awards by July 2025; interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    BRAIN Initiative: Brain-Behavior Quantification and Synchronization Transformative and Integrative Models of Behavior at the Organismal Level (U01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "BRAIN Initiative: Brain-Behavior Quantification and Synchronization – Transformative and Integrative Models of Behavior at the Organismal Level," aimed at advancing behavioral science through innovative research. This initiative seeks applications that focus on developing and validating tools for minimally invasive, high-resolution measurement of behavior, integrating multidimensional behavioral, neural, and environmental data, and creating new theoretical models to understand behavior as a complex dynamic system. With an anticipated funding commitment of approximately $8 million, the program emphasizes interdisciplinary collaboration and requires a Plan for Enhancing Diverse Perspectives (PEDP) to promote inclusivity. Interested applicants should submit their proposals by October 9, 2026, and can direct inquiries to grantsinfo@nih.gov for further information.
    BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed). This funding opportunity aims to enhance the understanding of brain function by developing innovative theories, models, and methods for analyzing complex neuroscience data, with a focus on creating tools that are widely accessible to the research community. The initiative emphasizes collaboration among various stakeholders, including theorists, modelers, and experimentalists, and requires detailed plans for resource and data sharing. Awards will be made for a duration of three years, with an anticipated annual funding of $6 million to support up to 15 projects, each receiving between $150,000 and $350,000 in direct costs. Interested applicants can find more information and submit inquiries via email to grantsinfo@nih.gov, with the application deadline set for November 8, 2027.
    Notice of Intent to Publish a Funding Opportunity Announcement for BRAIN Initiative Connectivity across Scales (BRAIN CONNECTS): Specialized Projects for Scalable Technologies (U01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a funding opportunity announcement for the BRAIN Initiative Connectivity across Scales (BRAIN CONNECTS): Specialized Projects for Scalable Technologies (U01 Clinical Trial Not Allowed). This initiative aims to foster innovative neurotechnologies and facilitate meaningful collaborations among researchers, with the official announcement expected in March 2025 and applications due by June 2025. The BRAIN Initiative is crucial for advancing our understanding of brain connectivity and developing scalable technologies that can enhance research in neuroscience. Interested applicants should note that there is no cost-sharing requirement, and the estimated award date is set for March 2, 2026. For further details, potential applicants are encouraged to stay updated as the synopsis is anticipated to be posted on September 13, 2024.
    Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Innovation Grants to Nurture Initial Translational Efforts (IGNITE)" aimed at developing and validating model systems for neurotherapeutic discovery. This initiative encourages proposals for animal models or ex vivo systems that accurately replicate the characteristics of specific neurological or neuromuscular disorders, with the goal of enhancing the translational relevance of these models to improve drug development processes. The program utilizes a phased award mechanism (R61/R33) and requires collaboration with clinical experts, along with a Plan for Enhancing Diverse Perspectives (PEDP) to promote inclusivity in research. The total funding available is $750,000 over three years, with a maximum of $499,000 in direct costs per year. Key submission dates begin with the earliest application due date of January 18, 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "NeuroNEXT Small Business Innovation in Clinical Trials," aimed at encouraging small businesses to conduct exploratory clinical trials of investigational agents related to neurological disorders. This initiative seeks applications for Phase II Small Business Innovation Research (SBIR) projects, with a budget of up to $3 million over five years, focusing on trials that align with the strategic plan of the National Institute of Neurological Disorders and Stroke (NINDS). The program is designed to foster public-private partnerships to enhance the development and commercialization of innovative therapies, ultimately improving clinical outcomes in neuroscience research. Interested applicants must adhere to a Community Engagement and Research Inclusion (CERI) plan, with the first application deadline set for January 5, 2025, and additional deadlines throughout 2026 and 2027. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (U01 Basic Experimental Studies with Humans Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a forthcoming funding opportunity titled "BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain" under the U01 cooperative agreement mechanism. This initiative aims to solicit applications for research that investigates fundamental questions in human neuroscience through direct access to the brain, leveraging surgical procedures to explore how the brain senses, perceives, and engages in various cognitive functions. The opportunity encourages collaborative efforts among diverse teams, including clinicians, scientists, and engineers, to propose innovative research plans that could lead to significant insights into nervous system disorders. Interested applicants should prepare for the application process, as the estimated synopsis will be posted on November 28, 2025, with a closing date for applications expected by February 27, 2026. For further inquiries, potential applicants can contact Dr. Hermon R. Gebrehiwet at 240-328-8371 or via email at BRAINResOppHu@ninds.nih.gov.